Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03936465
Title Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
C.S. Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field